SAO PAULO (Reuters) - Brazilian pharmaceutical company Hypera SA HYPE3.SA said on Wednesday it has agreed to buy Boehringer Ingelheim's Buscopan brand and other assets for 1.3 bln reais ($319 million).
On Tuesday, Reuters reported that Hypera was interested in a deal and was competing with rival EMS.
Reporting by Alberto Alerigi Jr., writing by Stephen Eisenhammer; Editing by Louise Heavens
Our Standards: The Thomson Reuters Trust Principles.